Highlights
NASDAQ: XENE       Xenon Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
13.99   +0.63 (4.72%)  13.40 - 14.15  717,180

Overview

 
Avg Volume (4 weeks):216,542
4 Weeks Range:8.62 - 14.95
4 Weeks Price Volatility (%):
84.83%
52 Weeks Range:5.41 - 14.95
52 Weeks Price Volatility (%):
89.94%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Xenon Pharmaceuticals Inc is a Canadian clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of therapeutics for orphan indications. The company has developed a gene therapy referred as Glybera for the treatment of a subset of patients with the orphan lipid disorder lipoprotein lipase deficiency. The other product candidates include TV-45070, GDC-0310, XEN801 and XEN901 and other compounds in preclinical and discovery pipeline.

  Be the first to like this.
 


 

3640  2100  313  2918 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 CHK 0.783+0.037 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers